To learn more about our technology and service, click here.
To learn about the new Macustat test for Macular Degeneration (AMD), click here.

Making a difference

Millions have waited years for the technology to finally arrive - hoping that one day they can take charge of their health and change the odds against blindness. Of every 30 people over the age of 50, one will be affected by glaucoma – a “silent” degenerative disease of the optic nerve. Estimates of the American Academy of Ophthalmology (AAO) , American Optometric Association (AOA), and the World Health Organization (WHO) indicate that more than 2 million in the US and 80 million in the world are affected by this disabling disease. Lack of symptoms until late in the disease course make detection difficult and often impossible before the onset of irreversible blindness. Much like cancer, glaucoma is insidious in nature and gives little notice. Most patients have 20/20 vision and enjoy a healthy and productive lifestyle despite advancing disease. A routine visit with your doctor, or even a regular exam for eye glasses, will not pick up the signs of glaucoma.

Peristat is the first to deliver on the promise of telemedicine and online disease screening and prevention. Now, a simple and effective online test can detect and help prevent one of the leading causes of blindness in the civilized world. Peristat has a 90% chance to detect glaucoma years before symptoms appear. With a routine yearly screening, as recommended by the leading medical authorities, you will be alerted to the very first signs of glaucoma, and will be able to seek timely treatment withan eye doctor. The Peristat screening test has been developed by ophthalmologists and glaucoma specialists at the leading medical institutions in the US. It is the product of years of advanced medical research. For more information on glaucoma screening and prevention, explore the recommended links on the side.

"Peristat, a unique telemedicine technology for home-based testing, offers you a new method of assessing your visual field (side vision) for signs of silent disease. The test can identify glaucoma, as well as other causes of visual damage in their early stages, before the onset of any symptoms. Early detection of glaucoma, a leading cause of vision loss world-wide in people over 50, is especially important to its treatment and long-term preservation of your sight.“ Don Minckler, MD, Professor of Ophthalmology

Glaucoma can affect everyone, even infants and children. It is most prevalent in adults over 50, who have the highest risk to develop the disease. The leading medical organizations (AAO, AOA, HEDIS) recommend routine screening every year. People who have diabetes, family history of glaucoma, as well as significant nearsightedness are at a particularly high risk for glaucoma. Annual screening with either Peristat or an office visit can provide you with security and peace of mind .

Doctors recommend annual glaucoma screening for adults over 50. Much like hypertension and cholesterol screening, the benefits of early detection are substantial.Glaucoma is an irreversible degenerative disease of the optic nerve which leads to visual impairment in both eyes. There is no cure for glaucoma, but timely treatment can halt the progression of the disease and prevent or delay blindness. For many, this means functional vision with no walking cane or a guide dog for years.

Peristat is a valuable test for people who have had a stroke or brain injury, as well as patients with multiple sclerosis. Central visual pathways are often affected with new or expanded blind spots in your peripheral vision. Peristat can easily detect such incidental scotomas so you and your neurologist can monitor their progression.

The Peristat screening test has been developed by ophthalmologists and glaucoma specialists at the leading medical institutions in the US. It is the product of years of advanced medical research. Fundamentally, Peristat is not a new diagnostic technology, only a novel way of delivery through a virtual online channel. Peristat is a perimetry device much like the specialized equipment in the eye doctor’s office. The perimetry tests scan your visual field, and create a high-fidelity contrast sensitivity map of your peripheral vision. These devices are the standard of care doctors use to diagnose glaucoma routinely.

Peristat’s technology is unique – it transforms your computer into a sophisticated diagnostic station so you can take the test anywhere, anytime. Our doctors and diagnostic specialists review the results within 24 hours.

Peristat has been extensively validated to ensure utmost reliability and accuracy. It has been featured at the premier academic medical forums, such as the ARVO, IPS. The results of clinical trials have also been published in the peer-review medical literature.

Yes. Peristat received FDA registration as a Perimetry Class I device in 2005.

The Peristat Guarantee:

At Peristat we have one vision – to help everyone else keep theirs! We are relentless in our pursuit of health and wellness. Our service commitment includes the Peristat Guarantee: You don’t get charged until you take a reliable test and our reviewers confirm the validity of your results. However, we do not promise 100% accuracy. No screening test is 100% accurate. All testing and results are confidential.

Generally, Peristat costs 3-4 times less than an office visit. For only $29.95 you can purchase an annual screening package. If you are referred by one of our affiliates and partners, the individual price may vary.

To learn more about our technology and service, click here.